A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis.

Sci Rep · 2015 · PMC4585926 · PMID 26412210

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients who developed anti-TNF antibodies showed a trend toward clinical improvement.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.